EIGHT-year-old leukemia patient Goh Ting Haw requires about RM800,000 to undergo Chimeric Antigen Receptor (CAR T-Cell) treatment in Singapore.
Ting Haw’s family is seeking public funding for the treatment which offers a recovery rate of over 60%.
One Hope Charity and Welfare Berhad, a non-profit organisation in Penang that helps the poor, has stepped in to channel the family’s request.
Chairman Chua Sui Hau said the boy was diagnosed with leukemia when he was 21 months old.
Chemotherapy sessions plus a bone marrow transplant done in 2018 have proven ineffective.
“Instead of going to school like other children, Ting Haw spends his time in hospitals.
“His condition reached a point that his testes were removed to prevent cancer cells from spreading.
“Undergoing the CAR T-Cell treatment in Singapore is his last resort, ” said Chua on Friday.
Ting Haw is currently in a palliative care unit with slim hopes of survival.
The boy’s father, assistant operations manager Goh Yee Min, 35, earns about RM7,000 monthly but his mother Khor Pei Ling, 35, quit her job to look after him.
“The couple found a hospital in Singapore which specialises in treating leukemia but treatment will cost SGD250,000 (RM772,742) including a nine-month stay there.
“The family is able to borrow enough money to cover daily expenses but not for the treatment, ” said Chua.
CAR T-cell therapy uses specially transformed T-cells to more specifically target cancer cells for immunotherapy.
Doctors first extract a sample of T-cells from the patient’s blood and recreate these T-cells to produce special structures called chimeric antigen receptors (CARs) on their surfaces.
When these modified CAR T-cells are re-injected into the patient’s body, it recognises and attacks cancer cells in the human body.
To help, call One Hope’s careline at 016-419 2192,019-232 2192 or 04-539 9212.